Bacterial Pathogens and Disease I Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Define pathogen, pathogenicity, virulence and toxigenicity

A

Pathogen: A microorganism capable of causing disease.
Pathogenicity: The ability of an infectious agent to cause disease.
Virulence: The quantitative ability of an agent to cause disease.
Toxigenicity: The ability of a microorganism to produce a toxin that contributes to the development of disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the mechanisms of virulence?

A

Adherence factors
Biofilms
Invasion of host cells and tissues
Toxins- endotoxins and exotoxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are exotoxins?

A

Heterogeneous group of proteins produced and secreted by living bacterial cells.
Produced by both gram negative and gram-positive bacteria.
Cause disease symptoms in host during disease.
Act via a variety of diverse mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do bacteria have exotoxins?

A

Cause disease? – may help transmission of disease, however in severe disease host may be a literal and evolutionary dead end.
However with many toxins the disease causing activity may be not be the primary function. Other activities
- Evade immune response
- Enable biofilm formation
- Enable attachment to host cells.
- Escape from phagosomes
All allowing for colonisation, niche establishment and carriage - Evolutionary advantage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What toxins does Staphylococcus aureus utilise?

A

Haemolytic toxins
- cause cells to lyse by forming pores
- Important cause of features of S. aureus disease.
- α,β,γ, toxins ,Panton Valentine Leukocidin (PVL), LukAB, LukED, LukMF
Phenol soluble modulins PSM
- Aggregate the lipid bilayer of host cells - lysis
Majority of S. aureus in humans is asymptomatic carriage in the nose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why does S. aureus have exotoxins?

A

PSMs allow bacteria to escape from the lysosomes
Alpha toxins blocks the binding of lysosomes to the phagosome
The PSM of staph aureus is really useful at killing other bacteria in the environment
Staph aureus cannot move, but releases PSM as it allows it to slide through certain media
Alpha and beta toxins especially help initiate the formation of biofilms, a community of bacteria, which can then interact with other molecules to form a secondary structure
PSM then helps chunks of that biofilm to move and then aids carriage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are exotoxins encoded?

A

Can be encoded by chromosomal genes Shiga toxin in Shigella dysenteriae, TcdA & TcdB in C. difficile
Many toxins coded by extrachromosomal genes
- Plasmids – Bacillus anthracis toxin, tetanus toxin
- Lysogenic bacteriophage – e.g. streptococcal pyrogenic exotoxins in Scarlet Fever, Diphtheria toxin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the classifications of exotoxins? What is the problem with this system?

A

As very diverse group of proteins and many ways to classify.
Classification can be by the toxins activity .
Membrane Acting Toxins – Type I
Membrane Damaging Toxins – Type II
Intracellular Toxins – Type III
This classification has its problems –
- Many toxins may have more than one type activity.
- As mechanisms better understood this classification tends to break down.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the characteristics of Type I exotoxins?

A
Act:
	- Act from without the cell
Interfere:
	- Interfere with host cell signalling by inappropriate activation of host cell receptors 
Target:
	- Target receptors include:
	· Guanylyl cyclase  → ↑  intracellular cGMP
	· Adenyl cyclase → ↑ intracellular cAMP
	· Rho proteins
	· Ras proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of a Type I exotoxin and what it does?

A

E. coli Stable Heat Toxin
Basically you have the heat stable E coli toxin binding to the CGC receptor leading to an increased production of cGMP which acts on protein kinases or the cystic fibrosis transmembrane receptor that affect an ion pump that controls the balance of chloride and bicarbonate ions
So now you have dysregulated secretion of chloride and bicarbonate ions and a knock on effect on the control of the proton-sodium pump
This leads on to a dysregulated secretion of sodium ions outside the cell, what follows? Water
Ergo diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the characteristics of Type II exotoxins?

A

Cause damage to the host cell membrane
1. Insert channels into host cell membrane.
- β sheet toxins e.g. S.aureus α – toxin, γ toxin, PVL
- α helix toxins – e.g. diphtheria toxin
2. Enzymatical damage e.g. S. aureus β- haemolysin, PSM
OR considered
1. Receptor mediated
2. Receptor Independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the characteristics of Type III exotoxins?

A

Active within the cell – must gain access to the cell
Usually 2 components – AB Toxins
- Receptor binding and translocation function – B
- Toxigenic (enzymatic) – A
- May be single or multiple B units e.g. Cholera toxin AB5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Type III AB toxins and what enzymatic components do they have?

A

Intracellular toxins- Type III- AB toxins
Enzymatic component A – wide variety of activities.
- ADP – ribosyl transferases - e.g. Exotoxin A of Pseudomonas aeruginosa, pertussis toxin.
- Glucosyltransferases – e.g. TcdA and TcdB of Clostridium difficile
- Deamidase – e.g. dermonecrotic toxin of Bordetella pertussis.
- Protease – e.g. Clostridial neurotoxins: botulism & tetanus
- Adenylcyclase - e.g. EF (Edema factor) toxin of Bacillus anthracis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the other two intracellular toxins?

A

Type III secretion and toxin injection
- Multi-molecule complexes that act like needles
- E.g. YopE in Yersinia species
Type IV secretion and toxin injection
- A multimeric secretory system that acts like a pump
- E.g. CagA in Helicobacter pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can exotoxins induce inflammatory cytokines release?

A

IL1, IL1β, TNF, IL 6, interferon γ, IL18
Mechanisms:
- Superantigen – non specific bridging of the MHC Class II and T- cell receptor leading to cytokine production. E.g. Staphylococcal Exfoliative Toxin A, Toxic Shock Syndrome Toxin 1 (TSST1)
- Via activation of the different inflammasome leading to release IL1 β and IL18 e.g. S. aureus toxin A, PVL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can toxins be fought against?

A

Toxins can be inactivated using formaldehyde or glutaraldehyde → toxoids
Toxoids are inactive proteins but still highly immunogenic – form the basis for vaccines.
- Tetanus Vaccine
- Diphtheria
- Pertussis (acellular).*
Treatment of toxin mediated disease can be affected by administering preformed antibodies to the toxin
- Diphtheria antitoxin – horse antibodies.
- Tetanus – pooled human immunoglobulin. Specific or normal.
- Botulism – horse antibodies
Experimental and research – monoclonal antibodies

17
Q

What is Clostridium difficile bacteria like?

A
  • gram-positive bacillus.
    • anaerobic.
    • spore-forming.
    • toxin-producing.
    • can be carried asymptomatically in the gut.
    • 3 toxins.
18
Q

What is the epidemiology of C.diff bacteria?

A
  • Common hospital acquired infection worldwide.
    • Spread by ingestion of spores – remain dormant in environment.
    • Coloniser of the human gut up to 5% in adults.
    • Risk factors – antibiotic use, age, antacids & prolonged hospital stay.
19
Q

How can antibiotics lead to a C. diff infection?

A

Thought to act by disrupting the microbial ecosystem within the gut.
Antibiotics provide a competitive advantage to spore forming anaerobes over non spore forming anaerobes.
Allows C. difficile colonisation and growth.
All antibiotics have potential for causing disease.
Some antibiotics worse than others:
- 2nd and 3rd generation cephalosporins
- Quinolones
- Clindamycin? (was considered one that was bad for C diff but now isn’t as clear)
Others less likely:
- Aminoglycosides
- Trimethoprim
- Vancomycin

20
Q

What toxins do C.diff bacteria have and with what domains?

A

Cytotoxin A - TcdA coded by tcdA gene
Cytotoxin B – TcdB coded by tcdB gene
Binary toxin – C. diff transferase (CDT) – minor role in disease
Tcd A and Tcd B – Type III AB toxins.
The A component of toxins are glycosylating enzymes.

Its domains include:
GTD- glucosyltransferase domain
CPD- cysteine protease domain that aids in the process of release of the toxic domain
DD- delivery hydrophobic domain allows for escape from membranous structures
RBD- receptor binding domain

21
Q

What are the steps involved of C.diff cytotoxins effects (5)?

A
  1. The RBD of the toxin binds to the specific host cell receptor
    1. Toxin is internalised
    2. The endosome then tends to acidify, that allows for an increase in activity of CPD and also the interaction of the delivery domain that allows for the release of the toxin from the endosome
    3. Now, when the GTD domain is free, thanks to the protease activity of the CPD and its delivery out of the endosome by DD, it binds to Rho GTPases
    4. This leads to mainly two effects:
      - Cytopathic effects- the breakdown and loss of cytoskeleton e.g. if it was an epithelial barrier you would lose the cell to cell junctions
      - Cytotoxic effects- Activation of the inflammasome, innate signalling system that detects damage in cells, leading to the production of ROSs, this all leads to a form of cell death called pyroptosis
22
Q

What are the stages of C.diff disease?

A

Asymptomatic
Watery diarrhoea
Pseudomembranous colitis
Toxic megacolon and peritonitis

23
Q

What are the clinical signs and symptoms of C.diff disease?

A

Clinical signs and symptoms
Raised white cell count in blood.
Detection of organisms and toxins in stool
- 2 phase test
· Glutamate dehydrogenase – detects if C. difficile organism present.
· Toxin enzyme linked immunosorbent assay (ELISA) for TcdA and TcdB toxins.
Detection of tcdA and tcdb genes – PCR
Colonoscopy – pseudomembranous colitis

24
Q

What are the possible treatments of C. diff disease?

A

Treatment dependent on severity and presence of surgical complications
Ideally removal of offending antibiotic – not always possible
Antibiotics fidaxomicin or metronidazole or vancomycin
Surgery – partial, total colectomy
Recurrent – faecal transplant.

25
Q

What is verocytotoxin Escherichia coli (VTEC) (STEC) disease?

A

VTEC, or Shiga-toxin (Stx) producing E. coli (STEC) can cause disease mild to life threatening disease.
Stx carried by some E. coli – most commonly O157:H7
- Identified usually by growth on sorbitol MacConkey agar (SMac) – does not ferment sorbitol and hence is clear.
- Other less common types not identified using SMac.

26
Q

How is E. coli transmitted?

A

E. coli O157:H7 naturally colonizes the gastrointestinal tracts of cattle who are generally asymptomatic.
Transmission
- Predominantly via consumption of contaminated food and water
- Person to person, particularly in child day-care facilities, and from
- Animal to person. E.g. in petting zoos, dairy farms, or camp grounds.
Very low infectious dose

27
Q

What is E.coli’s toxin pathogenesis like?

A

Toxin – Shiga like toxin (SLT) = shigatoxin (Stx) = verocytotoxin (VTEC)
Stx, Stx1, Stx1a, 1c, 1d Stx2a, 2c, 2d – variations in a.a. sequence
Gene carried on lysogenic bacteria.
Type III exotoxin – AB5
Enzymatic component A = N-Glycosidase
Bound to 5 B subunits

28
Q

What is the mechanism that the E.coli bacteria toxin uses?

A

Bind to receptor globotriaosylceramide Gb3 or globotetraosylceramide (Gb4) on host cell membrane
Bound toxin internalised by receptor mediated endocytosis.
Carried by retrograde trafficking via the Golgi apparatus to the endoplasmic reticulum.
The A subunit is cleaved off by membrane bound proteases
Once in the cytoplasm A1 and A2 disassociate
A1 binds to 28S RNA subunit – blocks protein synthesis.

29
Q

Describe the pathogenesis of STEC?

A

STEC closely adheres to the epithelial cells of the gut mucosa.
The route by which Stx is transported from the intestine to the kidney and other tissues is debated, possibly polymorphonuclear neutrophils (PMNs)
Bind to glomerular endothelial cells of kidney, cardiovascular and central nervous system.
Very high levels of Gb3 in kidney so kidneys most affected.
Thought that Stx favours inflammation resulting in microvascular thrombosis and inhibition of fibrinolysis.

30
Q

What can result from STEC disease?

A
Can be severe and life threatening
Children < 5 years  greatest risk
Abdominal cramps, watery or bloody diarrhoea – may not be present 
Haemolytic uraemic syndrome
	- Anaemia
	- Renal Failure
	- Thrombocytopaenia
Less common are neurological symptoms 
	- lethargy, 
	- severe headache, 
	- convulsions,
	- encephalopathy.
31
Q

How do you diagnose and treat STEC?

A
Diagnosis:
	- Clinical signs and symptoms
	- Haematological and biochemical evidence. 
	- Stool culture – Growth on SMac
	- PCR for Stx genes 
Treatment:
	- Supportive including renal dialysis and blood product transfusion 
	- Antibiotics have little to no role